AIP
TGAN

Ameritas Investment Partners’s Transphorm, Inc. Common Stock TGAN Stock Holding History

Ameritas Investment Partners’s Portfolio TGAN Stock Details TGAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,608
Closed -$7.89K – 3280
2024
Q1 		$7.89K Hold
1,608
– – ﹤0.01% 2876
2023
Q4 		$5.87K Hold
1,608
– – ﹤0.01% 2948
2023
Q3 		$3.57K Hold
1,608
– – ﹤0.01% 3029
2023
Q2 		$5.47K Hold
1,608
– – ﹤0.01% 3010
2023
Q1 		$6.42K Hold
1,608
– – ﹤0.01% 2820
2022
Q4 		$8.35K Hold
1,608
– – ﹤0.01% 2851
2022
Q3 		$8K Hold
1,608
– – ﹤0.01% 2869
2022
Q2 		$6K Buy
+1,608
New +$10.3K ﹤0.01% 2947

Ameritas Investment Partners's TGAN Position: Q2 2024 in Review

Ameritas Investment Partners sold out of Transphorm, Inc. Common Stock (TGAN) in Q2 2024, closing a stake of 1,608 shares — an estimated $7.89K sold.

Ameritas Investment Partners first reported a position in TGAN in Q2 2022 and held it in 8 quarters. The position peaked at $8.35K in Q4 2022. 0 funds tracked by Wall St. Rank hold TGAN as of Q2 2024.

  • Ameritas Investment Partners reported no remaining Transphorm, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Ameritas Investment Partners sold 1,608 Transphorm, Inc. Common Stock shares in Q2 2024, an estimated $7.89K.
  • Ameritas Investment Partners first reported a position in Transphorm, Inc. Common Stock in Q2 2022 and held it in 8 quarters.
  • Ameritas Investment Partners's Transphorm, Inc. Common Stock position peaked at $8.35K in Q4 2022.
  • 0 funds tracked by Wall St. Rank held Transphorm, Inc. Common Stock as of Q2 2024.

Based on Ameritas Investment Partners's 13F filing for Q2 2024, filed 13 Aug 2024.